Invention Grant
- Patent Title: Long lasting drug formulations
- Patent Title (中): 持久的药物配方
-
Application No.: US13160632Application Date: 2011-06-15
-
Publication No.: US09127084B2Publication Date: 2015-09-08
- Inventor: Andrew L. Pearlman , Baruch S. Stern
- Applicant: Andrew L. Pearlman , Baruch S. Stern
- Applicant Address: IL Misgav
- Assignee: Medgenics Medical Israel Ltd.
- Current Assignee: Medgenics Medical Israel Ltd.
- Current Assignee Address: IL Misgav
- Agency: McNeill Baur PLLC
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K38/00 ; C07K14/505 ; A61K48/00 ; C12N7/00 ; C12N15/86 ; A61K31/70 ; A61K38/18 ; A61K38/21
Abstract:
The present invention is directed to long-lasting erythropoietin therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes erythropoietin.
Public/Granted literature
- US20110286983A1 LONG LASTING DRUG FORMULATIONS Public/Granted day:2011-11-24
Information query
